76
Participants
Start Date
July 5, 2016
Primary Completion Date
June 19, 2019
Study Completion Date
February 1, 2022
Carfilzomib
Cyclophosphamide
Dexamethasone
Cross Cancer Institute, Edmonton
Regional Health Authority B, Zone 2, Saint John
QEII Health Sciences Centre, Halifax
Kingston Health Sciences Centre, Kingston
London Regional Cancer Program, London
Ottawa Hospital Research Institute, Ottawa
University Health Network, Toronto
CIUSSS de l'Est-de-I'lle-de-Montreal, Montreal
CHUQ-Pavillon Hotel-Dieu de Quebec, Québec
Collaborators (2)
Amgen
INDUSTRY
Canadian Myeloma Research Group
OTHER
Canadian Cancer Trials Group
NETWORK